A retrospective analysis of outpatients with heart failure revealed rates of angiotensin converting enzyme inhibitor and β blocker use similar to those achieved in recent randomized trials. Short-term survival was high.
Background: Randomized clinical trials have demonstrated improvement in mortality with angiotensin converting enzyme inhibitors (ACEIs), β blockers and aldosterone antagonists. The use of these lifesaving treatments remain inadequate.
Aim: To determine the clinical features, aetiology, treatment and short-term survival of heart failure in a cardiology private practice in Jamaica.